Metabolic Syndrome Abolishes Glucagon-Like Peptide 1 Receptor Agonist Stimulation of SERCA in Coronary Smooth Muscle

Metabolic syndrome (MetS) doubles the risk of adverse cardiovascular events. Glucagon-like peptide 1 (GLP-1) receptor agonists induce weight loss, increase insulin secretion, and improve glucose tolerance. Studies in healthy animals suggest cardioprotective properties of GLP-1 receptor agonists, per...

Descripción completa

Detalles Bibliográficos
Autores principales: Dineen, Stacey L., McKenney, Mikaela L., Bell, Lauren N., Fullenkamp, Allison M., Schultz, Kyle A., Alloosh, Mouhamad, Chalasani, Naga, Sturek, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2015
Materias:
Pharmacology and Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4542436/
https://www.ncbi.nlm.nih.gov/pubmed/25845661
http://dx.doi.org/10.2337/db14-1790

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4542436/
https://www.ncbi.nlm.nih.gov/pubmed/25845661
http://dx.doi.org/10.2337/db14-1790

Ejemplares similares